Tirzepatide 10mg

Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This 10mg lyophilized research vial is intended for laboratory studies into metabolic syndrome, insulin resistance, body weight regulation, and type 2 diabetes models. Tirzepatide has shown remarkable results in clinical research, making it a high-interest compound in modern metabolic science.